AMR locations nationwide are currently enrolling in investigational Adult RSV vaccine clinical research studies. Respiratory Syncytial Virus – or RSV – is most commonly discussed in children ages newborn to four. However, RSV, much like the flu or coronavirus, can cause long-term damage to the lungs. It can be life-threatening for adults 60 years and older and for those with compromised health conditions.

According to the CDC, it is estimated that more than 177,000 older adults are hospitalized and 14,000 of them die in the United States due to RSV infections per year. In 2018, more elder Americans died from RSV infection than the common flu.

To learn more, call our enrollment line: 1-888-259-1231.

To find an AMR location near you, visit www.amrllc.com/locations/

AMR locations nationwide are currently conducting several COVID-19 investigational clinical research studies. As with all studies, some exclusions will apply. However, we will have multiple studies needing participants from all walks of life. Compensation will be available for time and travel.

COVID-19 Investigational Vaccine (ages 16+) (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase I)
COVID-19 Investigational Vaccine Clinical Research Study (Phase II)
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase I)
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase I)
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
COVID-19 Investigational Treatment Clinical Research Study (Phase II)
COVID-19 Investigational Vaccine (ages 18+ and 5-17) (Phase III)
COVID-19 Investigational Vaccine (ages 16+) (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
COVID-19 Investigational Vaccine (ages 16+) (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase II)
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
COVID-19 Investigational Vaccine (ages 16+) (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase III)

AMR has multiple Healthy Volunteer Clinical Research Studies enrolling throughout the continental United States.  A “healthy volunteer” is someone with no known significant health problems who participates in a clinical research study to test a new drug, an investigational vaccination, a medical device or a medical intervention.    No insurance is required and qualified volunteers may receive compensation for their time and travel.  Listed below are our current and upcoming Healthy Volunteer clinical research studies listed by indication.

RSV Vaccine Clinical Research Study (healthy volunteers ages 60+)

This is an Investigational RSV Vaccine Clinical Research Study for healthy volunteers 60+ years of age. Respiratory syncytial virus (RSV) causes infections of the lungs and respiratory tract. In adults and older, healthy children, RSV symptoms are mild and typically mimic the common cold.

ALL AMR LOCATIONS NATIONWIDE

Flu Vaccine Clinical Research Study (healthy volunteers 50+)

This Investigational Flu Vaccine Clinical Research Study is for healthy volunteers 50 years of age and older.

Kansas City, Missouri: 816-943-0770
kansascity[email protected]

Lexington, Tennessee: 859-264-8999
[email protected]

Mobile, Alabama: 251-414-1984
[email protected]

Newton, Kansas: 316-283-0828
[email protected]

Phoenix, Arizona: 602-759-7559
[email protected]

Wichita-East, Kansas: 316-689-6652
[email protected]